跳至主要内容
临床试验/NCT05782049
NCT05782049招募中不适用

Ultrasound Characteristics of the Salivary Glands in Patients With Rheumatoid Arthritis

University Hospital, Clermont-Ferrand2 个研究点 分布在 1 个国家目标入组 210 人开始时间: 2023年2月2日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
210
试验地点
2
主要终点
OMERACT (Outcome Measures in Rheumatology) B-mode ultrasound homogeneity score greater than or equal to 2 in at least one of the 4 salivary glands

研究概览

简要总结

The prevalence of Sjogren's syndrome (SS) in rheumatoid arthritis (RA) patients varies from 3.5 to 31%. Between 30% and 90% of patients with (RA) have dry eye and/or mouth syndrome. To date, no studies have assessed whether RA patients have echostructural changes in their salivary glands suggestive of SS and the factors associated with these changes.The aim of this study is to investigate if there are changes in the echostructure of the salivary glands of RA patients, especially in patients with dry syndrome.

详细描述

The EchoPR study is an exploratory pathophysiology, cross-sectional, case-control study.

The aim is to study the echo-structure of the salivary glands of patients with RA ( group of 70 patients), in comparison to patients with SS (suspected of strong alteration of the echo-structure)(group of 70 patients) and patients with sicca, asthenia, polyalgia syndrome (SAPS)(group of 70 patients).

After a standard consultation with the rheumatologist, patients in each group will have an salivary gland ultrasound to assess the homogeneity of the echostructure of the parotid and submandibular salivary glands. A salivary flow measurement for 15 minutes and a Schirmer test to determine tear secretion for 5 minutes are also performed. All of these tests are performed during a single visit, so the total study time for the patient is one hour. Patient recruitment is expected to last 1 year.

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Single Group
主要目的
Other
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patient, male or female, over 18 years of age, followed in the Rheumatology Department of the Clermont-Ferrand University Hospital, capable of giving informed consent to participate in the research.
  • For RA subjects: Diagnosis of rheumatoid arthritis meeting the ACR/EULAR 2010 classification criteria.
  • For SS subjects: Diagnosis of primary Sjögren's syndrome meeting the ACR/EULAR 2016 criteria.
  • For SAPS subjects: Patients with dry syndrome not meeting the criteria for SS

排除标准

  • Not covered by social security
  • Minors or adults under the protection of the law or under the protection of justice.
  • Pregnant or breastfeeding women
  • Refusal to participate
  • Interference with results or classification bias: secondary causes of dry syndrome: Previous radiotherapy of the face and neck, AIDS, Hepatitis C, Sarcoidosis, Amyloidosis, Hyper-IgG4 syndrome

结局指标

主要结局

OMERACT (Outcome Measures in Rheumatology) B-mode ultrasound homogeneity score greater than or equal to 2 in at least one of the 4 salivary glands

时间窗: 10 minutes

The echostructure of the gland will be graded from 0 to 4 according to the OMERACT score : * 0: normal appearance * Grade 1: minimal inhomogeneity without hypoechoic/anechoic areas * Grade 2: moderate inhomogeneity with focal hypoechoic or anechoic areas * Grade 3 severe inhomogeneity with diffuse hypoechoic or anechoic areas of the whole gland or fibrous gland

次要结局

  • Color Doppler ultrasound vascularity score of OMERACT greater than or equal to 2 on at least one of the 4 salivary glands(10 minutes)
  • Surface of the submandibular salivary glands(2 minutes)
  • Length and width of the parotid glands(2 minutes)
  • Length of the submandibular glands(2 minutes)

研究者

发起方
University Hospital, Clermont-Ferrand
申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验